• High-frequency chest wall oscillation in the treatment of children with community-acquired pneumonia

High-frequency chest wall oscillation in the treatment of children with community-acquired pneumonia

SOVREMENNAYA PEDIATRIYA.2018.4(92):55-59; doi 10.15574/SP.2018.92.55

Usenko D. V.
Odesa National Medical University, Ukraine

High-frequency chest wall oscillation (HFCWO) is one of the innovative methods for restoring the drainage of bronchial tree and the improving of respiratory function (RF) in children with acute community-acquired pneumonia (CAP).
Objective: to evaluate the efficacy and safety of using the method of HFCWO in complex therapy (CT) of CAP in children.
Material and methods. We examined 56 children (the main group (MG) included 36 children; the control group (CG) – 20 paediatric patients) aged 6–16 years with CAP. The children of MG were administered CT with HFCWO. The CG obtained baseline therapy without HFCWO. The changes in clinical symptoms and indicators of RF in children with CAP using of HFCWO were studied.
Results. The improvement of clinical symptoms in children of MG manifested as a decrease in dyspnoea at rest in 91.7% of children and with physical activity in 86.1% of children, a reducing intensity of productive cough in 75.0% of children; the disappearance of moist rales in the lungs in 77.8% of children was identified. Improvement of RF parameters in the children of MG with CAP occurred due to a significant improvement in VC, FVC, FEV1, MEF75, and PEF.
Conclusions. The obtained data are indicative of the favourable influence of HFCWO on the clinical symptoms and RF indicators in children with CAP. The advantages of this method are efficacy, safety and compatibility with other methods of bronchial drainage.
Key words: community-acquired pneumonia, drainage function of bronchi, high-frequency chest wall oscillation, children.

References

1. WHO. Information Bulletin No. 331 (2013, Nov). http://www.who.int/mediacentre/factsheets/fs331/ru/.

2. Maidannik VG, Yemchinskaya YeO. (2014). Clinical guidelines for the diagnosis and treatment of community-acquired pneumonia in children from the point of view of evidence-based medicine. Kyiv: 43.

3. Marushko YuV, Grachova MG. (2013). Experience of using the drug cefodox in the treatment of community-acquired pneumonia in children. Sovremennaya pediatriya. 8(56): 58-62.

4. Meshcheryakova NN, Chernyak AV. (2011). Influence of methods of high-frequency chest oscillation on the functional state of the lung in patients with pulmonary pathology. Pulmonology. 5: 57-60. https://doi.org/10.18093/0869-0189-2011-0-5-57-60

5. Kostromina VP, Strizh VO. (2010). Pneumonia in children: the principles of start-up controlled treatment. Pediatrician. 2: 5-11.

6. Khan MA, Linok VA, Lyan NA, Mikitchenko NA (2014). The use of high-frequency chest oscillation in the treatment of children with cystic fibrosis. Pediatrics. 93; 4: 80-86.

7. Khodzitskaya VK, Khodzitskaya SV. (2010). Violation and correction of mucociliary clearance in diseases of the respiratory tract and ENT organs Diseases and antibiotics. 1(03).

8. Chikina SYu, Belevsky AS. (2012). Mucociliary clearance in norm and in pathology. Atmosphere. Pulmonology and allergology. 1: 2-5.

9. Allan JS, Garrity JM, Donahue DM. (2009). High_frequency chest_wall compression during the 48 hours following thoracic surgery. Respir. Care. 54(3): 340-343. PMid:19245727

10. Anderson CA, Palmer CA, Ney AL et al. (2008). Evaluation of the safety of high-frequency chest wall oscillation (HFCWO) therapy in blunt thoracic trauma patients. J Trauma Manag Outcomes. 2(1): 8. https://doi.org/10.1186/1752-2897-2-8; PMid:18837992 PMCid:PMC2569011

11. Bourdin A, Burgel P, Chanez P et al. (2009). Recent advances in COPD: pathophysiology, respiratory physiology and clinical aspects, including comorbidities. Eur Respir Rev. 18: 198-212. https://doi.org/10.1183/09059180.00005509; PMid:20956145

12. Chakravorty I, Chahal K, Austin G. (2011). A pilot study of the impact of high-frequency chest wall oscillation in chronic obstructive pulmonary disease patients with mucus hypersecretion. Int J Chron Obstruct Pulmon Dis. 6: 693-699. https://doi.org/10.2147/COPD.S22896; PMid:22259246 PMCid:PMC3257955

13. Chatburn RL. (2007). High-freguency assisted airway clearance. Respir Care. 52(9): 1224-1237. PMid:17716388

14. Crescimanno G, Marrone O. (2010). High frequency chest wall oscillation plus mechanical in exsufflation in Duchenne muscular dystrophy with respiratory complications related to pandemic Influenza A/H1N1. Rev Port Pneumol. 16(6): 912-916. https://doi.org/10.1016/S0873-2159(15)31254-X

15. Kempainen RR, Milla C, Dunitz J et al. (2010). Comparison of settings used for high frequency chest-wall compression in cystic fibrosis. Respir Care. 55(6): 695-701. PMid:20507651

16. Lester MK, Flume PA. (2009). Airway-clearance therapy guidelines and implementation. Respir Care. 54(6): 733-750. https://doi.org/10.4187/002013209790983205; PMid:19467161

17. Mall MA. (2008). Role of cilia, mucus, airway surface liquid in mucociliary dysfunction: lessons from mouse models. J Aerosol Med Pulm Drug Deliv. 21(1): 13-24. https://doi.org/10.1089/jamp.2007.0659; PMid:18518828

18. Mannino DM, Buist AS. (2007). Global burden of COPD: risk factors, prevalence, and fyture trends. Lancet. 370: 765-773. https://doi.org/10.1016/S0140-6736(07)61380-4

19. Osman LP, Roughton M, Hodson ME, Pryor JA. (2010). Short term comparative study of high frequency chest wall oscillation and European airway clearance techniques in patients with cystic fibrosis. Thorax. 65(3): 196-200. https://doi.org/10.1136/thx.2008.111492; PMid:19703826 PMCid:PMC2922723

20. Yuan N, Kane P, Shelton K et al. (2010). Safety, tolerability, and efficacy of high-frequency chest wall oscillation in pediatric patients with cerebral palsy and neuromuscular diseases: an exploratory randomized controlled trial. J Child Neurol. 25(7): 815. https://doi.org/10.1177/0883073809350223; PMid:20357238